For all of the quality care it delivers, the U.S. health care system is one of the most dysfunctional sectors of the U.S. economy. The government spends nearly 50 cents of every dollar spent on health care, most consumers are almost entirely insulated from the cost of their decisions, and employers decide what kind of health insurance their employees get.
But while the U.S. health care system begs for reform, the Patient Protection and Affordable Care Act only exacerbates all of the current problems, promising to devolve into a price-controlled system rationed and micromanaged by bureaucrats.
IPI believes there are much better options: reform the tax treatment of health insurance; remove the state and federal mandates and regulations that make coverage more expensive; pass medical liability reform; and promote policies that create value-conscious shoppers in the health care marketplace.
Ending Obamacare Won't End Health Care Coverage
Concerns that the Supreme Court could overture Obamacare, creating more uninsured in a pandemic, are largely overblown.
Responding to the Coronavirus Crisis and Building a Stronger Health Sector for the Future
An open letter to the American people from 75 participants in the Health Policy Consensus Group and other health care leaders providing important guidance to policymakers following lessons learned from the coronavirus crisis, especially the imperative for greater flexibility in our health sector.
Why All the Handwringing Over a COVID-19 Vaccine's Effectiveness?
Before we demand that a COVID-19 vaccine "prevents" contracting the disease in all cases, consider the flu vaccine.
Study: Biosimilars Can Help Address Economic Shortfalls
Patients and payors can benefit from more affordable treatment in the wake of the pandemic.
Liberals: Which 'Science' Are We Supposed to Believe?
What some want to call science is increasingly politics masquerading as science. And nothing has demonstrated that better than the coronavirus.
Attempts to Degrade Drug Patents are Counterproductive in This Pandemic
Compulsory licensing deters innovators from investing in drug discovery. It won’t reduce what patients pay.
Bring American Medical Manufacturing Back Home
Important legislation has been proposed that would encourage medical and pharmaceutical manufacturing to relocate to the U.S. by providing potent tax incentives instead of threats of government force.
Biosimilars Are Key in Good Health, Taxpayer Savings
Americans are the world’s top users of generics, but not of biosimilars. State and local governments should encourage a wider uptake for their own employees as an important start—and a much-needed cost savings.
Less Than Two-Thirds of Americans Are 'Very' or 'Somewhat' Interested in COVID-19 Vaccinations
If a shot becomes available, there's a good chance more people will choose to vaccinate without a government mandate.
Will Government Mandate COVID-19 Vaccinations?
If the government determines that vaccinations are essential to stemming the spread of the disease, would it– could it–mandate vaccination compliance? Apparently, it can—and it might.
Total Records: 702
